162 related articles for article (PubMed ID: 16351191)
21. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM
Retina; 2001; 21(5):499-508. PubMed ID: 11642380
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy for age-related macular degeneration.
Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
[TBL] [Abstract][Full Text] [Related]
24. Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle.
García-Díaz M; Kawakubo M; Mroz P; Sagristà ML; Mora M; Nonell S; Hamblin MR
J Control Release; 2012 Sep; 162(2):355-63. PubMed ID: 22841794
[TBL] [Abstract][Full Text] [Related]
25. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
Parodi MB; Da Pozzo S; Ravalico G
Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
[TBL] [Abstract][Full Text] [Related]
26. Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study.
Saviano S; Leon PE; Mangogna A; Tognetto D
Digit J Ophthalmol; 2016; 22(2):46-53. PubMed ID: 27582675
[TBL] [Abstract][Full Text] [Related]
27. [Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for occult and classic CNV in AMD].
Maier M; Haas K; Feucht N; Fiore B; Winkler von Mohrenfels C; Clos A; Lohmann C
Klin Monbl Augenheilkd; 2008 Jul; 225(7):653-9. PubMed ID: 18642209
[TBL] [Abstract][Full Text] [Related]
28. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy.
Liang H; Zhou Z; Luo R; Sang M; Liu B; Sun M; Qu W; Feng F; Liu W
Theranostics; 2018; 8(18):5059-5071. PubMed ID: 30429886
[TBL] [Abstract][Full Text] [Related]
29. Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration.
Parmeggiani F; Costagliola C; Gemmati D; D'Angelo S; Perri P; Scapoli GL; Catozzi L; Federici F; Sebastiani A; Incorvaia C
Pharmacogenet Genomics; 2007 Dec; 17(12):1039-46. PubMed ID: 18004208
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
[TBL] [Abstract][Full Text] [Related]
31. [PDT (photodynamic therapy) treatment of choroidal neovascularisations (CNV) associated with presumed ocular histoplasmosis syndrome (POHS)].
Ringwald A
Klin Monbl Augenheilkd; 2010 Jun; 227(6):507-9. PubMed ID: 20560102
[No Abstract] [Full Text] [Related]
32. Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration.
Obata R; Yanagi Y; Kami J; Takahashi H; Inoue Y; Tamaki Y
Jpn J Ophthalmol; 2006; 50(4):354-360. PubMed ID: 16897221
[TBL] [Abstract][Full Text] [Related]
33. Intensive tumor suppression by anti-angiogenic photodynamic therapy with polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Nango M; Oku N
Cell Mol Biol Lett; 2002; 7(2):301. PubMed ID: 12097971
[No Abstract] [Full Text] [Related]
34. Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy.
Jang WD; Nishiyama N; Zhang GD; Harada A; Jiang DL; Kawauchi S; Morimoto Y; Kikuchi M; Koyama H; Aida T; Kataoka K
Angew Chem Int Ed Engl; 2005 Jan; 44(3):419-23. PubMed ID: 15624158
[No Abstract] [Full Text] [Related]
35. [Indications for photodynamic therapy in age-related macular degeneration].
Soubrane G; Kuhn D; Coscas G
J Fr Ophtalmol; 2004 Jan; 27(1):79-80. PubMed ID: 14968084
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment photosensitizer dosimetry reduces variation in tumor response.
Zhou X; Pogue BW; Chen B; Demidenko E; Joshi R; Hoopes J; Hasan T
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1211-20. PubMed ID: 16504761
[TBL] [Abstract][Full Text] [Related]
37. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
38. Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration.
Gaynes BI; Fiscella RG
Expert Opin Drug Saf; 2004 Jul; 3(4):345-61. PubMed ID: 15268651
[TBL] [Abstract][Full Text] [Related]
39. Treatment of rubeosis iridis with photodynamic therapy with verteporfin--A new therapeutic and prophylactic option for patients with the risk of neovascular glaucoma?
Müller VA; Ruokonen P; Schellenbeck M; Hartmann C; Tetz M
Ophthalmic Res; 2003; 35(1):60-4. PubMed ID: 12566865
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
